Allogene Therapeutics, Inc. Variable Lease, Payment
Allogene Therapeutics, Inc. (ALLO) reported Variable Lease, Payment of $1.10 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:VariableLeasePayment · last filed 2020-02-27
- Allogene Therapeutics, Inc. variable lease, payment for the quarter ending 2019-12-31 was $200.00K.
- Allogene Therapeutics, Inc. variable lease, payment for the quarter ending 2019-09-30 was $300.00K.
- Allogene Therapeutics, Inc. variable lease, payment for the quarter ending 2019-06-30 was $300.00K.
- Allogene Therapeutics, Inc. variable lease, payment for the quarter ending 2019-03-31 was $300.00K.
- Allogene Therapeutics, Inc. variable lease, payment for fiscal 2019 was $1.10M.
| Period end | Variable Lease, Payment 3 month | Variable Lease, Payment 6 month | Variable Lease, Payment 9 month | Variable Lease, Payment 12 month |
|---|---|---|---|---|
| 2019-12-31 | $200.00K derived: 10-K 12 month − 3 quarters · filed 2020-02-27 | $500.00K derived: sum of 2 quarters · filed 2020-02-27 | $800.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.10M 10-K · filed 2020-02-27 |
| 2019-09-30 | $300.00K 10-Q · filed 2019-11-05 | $600.00K derived: sum of 2 quarters · filed 2019-11-05 | $900.00K derived: sum of 3 quarters · filed 2019-11-05 | |
| 2019-06-30 | $300.00K 10-Q · filed 2019-08-07 | $600.00K derived: sum of 2 quarters · filed 2019-08-07 | ||
| 2019-03-31 | $300.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |